Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Short guide to identifying dividend ETFs with the absolute lowest fees and what to consider beyond price.
27,457 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
ON Semiconductor is rising fast as 2025's downturn loosens its grip. This report explores the catalysts, risks, and t...
Markets brace for a potential rate move at the July FOMC meeting as JPMorgan Asset Management weighs in on Warsh-era ...
Visa reports solid growth as it guards a $700 billion payments empire against threats from real-time rails and crypto...
A new leadership ethos is taking hold among billionaire founders and operators. As markets shift in early 2026, many ...
Oro Labs has secured a $100 million Series C to scale its AI-powered procurement orchestration platform, expanding it...
Tesla stock has swung wildly in recent years, prompting timing questions. This guide explains what 'late' means for T...
Ford stock surged 8% on Friday, easily outpacing General Motors and Stellantis as investors focus on Ford Energy and ...
As June begins, NVIDIA has surged to the top of investor lists as the biggest June bet on AI infrastructure, backed b...
As ad-tech rotates from pandemic-driven momentum to more measured growth, The Trade Desk faces a pivotal moment. This...
Lucid has wowed investors with fast-paced progress and bold promises. Yet the stock faces real headwinds. Here are th...
One member of the famous seven has slipped 22% from its high. This article outlines whether the drop is a buying sign...